版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
各論促紅細(xì)胞生成素Erytropoietin,EPO腎臟,間質(zhì)細(xì)胞(組織缺氧誘導(dǎo)產(chǎn)生EPO)刺激和調(diào)節(jié)紅細(xì)胞的生成:促進(jìn)紅系細(xì)胞的生長(zhǎng),分化和增殖,促進(jìn)紅系池的擴(kuò)大;促進(jìn)紅細(xì)胞成熟;抗氧化作用臨床應(yīng)用:腎功能衰竭引起的貧血癌性貧血結(jié)締組織病貧血骨髓增生異常綜合癥貧血不良反應(yīng):腎性/非腎性貧血EpoRisaproteinthatinhumansisencodedbytheEPORgene.EpoRisa59kDapeptideandisamemberofthecytokinereceptorfamily.EpoRpre-existsasdimerswhichuponbindingofa34kDaliganderythropoietin(Epo),changesitshomodimerizedstate.TheseconformationalchangesresultintheautophosphorylationofJak2kinasesthatarepre-associatedwiththereceptor(i.e.,EpoRdoesnotpossessintrinsickinaseactivityanddependsonJak2activity).TheJAK-STATsystemconsistsofthreemaincomponents:(1)areceptor(2)Januskinase(JAK)and(3)SignalTransducerandActivatorofTranscription(STAT).ManyJAK-STATpathwaysareexpressedinwhitebloodcells,andarethereforeinvolvedinregulationoftheimmunesystem.JAKs,whichhavetyrosinekinaseactivity,bindtosomecellsurfacecytokinereceptors.ThebindingoftheligandtothereceptortriggersactivationofJAKs.Withincreasedkinaseactivity,theyphosphorylatetyrosineresiduesonthereceptorandcreatesitesforinteractionwithproteinsthatcontainphosphotyrosine-bindingSH2domains.STATspossessingSH2domainscapableofbindingthesephosphotyrosineresiduesarerecruitedtothereceptors,andarethemselvestyrosine-phosphorylatedbyJAKs.ThesephosphotyrosinesthenactasbindingsitesforSH2domainsofotherSTATs,mediatingtheirdimerization.DifferentSTATsformhetero-orhomodimers.ActivatedSTATdimersaccumulateinthecellnucleusandactivatetranscriptionoftheirtargetgenes.STATsmayalsobetyrosine-phosphorylateddirectlybyreceptortyrosinekinases,suchastheepidermalgrowthfactorreceptor,aswellasbynon-receptortyrosinekinasessuchasc-src.TypeIcytokinereceptors,whosemembershavecertainconservedmotifsintheirextracellularamino-aciddomain.TheIL-2receptorbelongstothischain,whoseγ-chain(commontoseveralothercytokines)deficiencyisdirectlyresponsibleforthex-linkedformofSevereCombinedImmunodeficiency(X-SCID).TypeIIcytokinereceptors,whosemembersarereceptorsmainlyforinterferons.Immunoglobulin(Ig)superfamily,whichareubiquitouslypresentthroughoutseveralcellsandtissuesofthevertebratebodyTumornecrosisfactorreceptorfamily,whosemembersshareacysteine-richcommonextracellularbindingdomain,andincludesseveralothernon-cytokineligandslikereceptors,CD40,CD27andCD30,besidestheligandsonwhichthefamilyisnamed(TNF).Chemokinereceptors,twoofwhichactingasbindingproteinsforHIV(CXCR4andCCR5).TheyareGproteincoupledreceptors.TGFbetareceptorsAclassificationofcytokinereceptorsbasedontheirthree-dimensionalstructurehasbeenattempted.(Suchaclassification,thoughseeminglycumbersome,providesseveraluniqueperspectivesforattractivepharmacotherapeutictargets.)生長(zhǎng)因子類藥物胰島素樣生長(zhǎng)因子(IGF,IGF-I,IGF-II)肝臟(進(jìn)入血液)IGF-I:70個(gè)氨基酸,3個(gè)二硫鍵;IGF-II:67個(gè)氨基酸,3個(gè)二硫鍵。A+C+B構(gòu)成。生物學(xué)特性:胚胎發(fā)育生長(zhǎng)啟動(dòng)效應(yīng)提高腎功能影響生殖作用臨床應(yīng)用:治療胰島素受體紊亂(機(jī)理不甚明確)促生長(zhǎng)作用治療骨質(zhì)疏松硬化癥IGF-I型受體結(jié)構(gòu)與胰島素受體(Insulinreceptor,Ir)相似,由α和β兩個(gè)亞基構(gòu)成α2β2四聚體的糖蛋白,α亞基是配體結(jié)合部位,β亞單位具有內(nèi)在的酪氨酸激酶活性。表皮生長(zhǎng)因子Humanepidermalgrowthfactor,hEGF是一種多功能的生長(zhǎng)因子,在體內(nèi)體外都對(duì)多種組織細(xì)胞有強(qiáng)烈的促分裂作用來(lái)源:?jiǎn)魏思?xì)胞,外胚層,腎臟等結(jié)構(gòu):由53個(gè)氨基酸組成的小分子多肽,分子內(nèi)有三對(duì)二硫鍵,不含糖基,對(duì)酸、堿、熱等理化因素均較穩(wěn)定。生物學(xué)特性:刺激皮膚和中胚層細(xì)胞生長(zhǎng)。對(duì)上皮細(xì)胞(內(nèi)皮),有促生長(zhǎng)和增殖活性。能極強(qiáng)地促進(jìn)各種表皮組織生長(zhǎng)。加快K+和葡萄糖等小分子進(jìn)入細(xì)胞。作用原理:增加細(xì)胞移動(dòng),分裂生長(zhǎng),細(xì)胞間質(zhì)蛋白合成,促進(jìn)新血管形成,促進(jìn)核酸蛋白質(zhì)合成。臨床:治療潰瘍,燒傷,其他潰瘍是皮膚或黏膜表面組織的限局性缺損、潰爛,其表面常覆蓋有膿液、壞死組織或痂皮,愈后遺有瘢痕,可由感染、外傷、結(jié)節(jié)或腫瘤的破潰等所致,其大小、形態(tài)、深淺、發(fā)展過(guò)程等也不一致。常合并慢性感染,可能經(jīng)久不愈。hEGF與特異的跨細(xì)胞膜表面的EGFR結(jié)合后,刺激了EGFR復(fù)合物中的酪氨酸激酶的活性,通過(guò)EGFR復(fù)合物的自磷酸化作用,在細(xì)胞內(nèi)形成快速的信息傳遞網(wǎng)絡(luò),激活蛋白酶和磷酸酯酶等的一系列生化反應(yīng),促進(jìn)體內(nèi)Ca2+、K+和糖等低分子物大量進(jìn)入細(xì)胞內(nèi)(主動(dòng)運(yùn)輸),糖酵解量增大,RNA與蛋白質(zhì)合成增多,作用一段時(shí)間后,EGFR復(fù)合物開(kāi)始促進(jìn)DNA合成,并由此趨向刺激內(nèi)皮細(xì)胞、單核細(xì)胞等多種細(xì)胞分裂、增殖和分化,使之向創(chuàng)傷部位遷移,加速啟動(dòng)創(chuàng)傷組織再生、修復(fù)和胞外間質(zhì)形成。另一方面,hEGF能增加其他內(nèi)源性生長(zhǎng)因子,促進(jìn)羥脯氨酸合成,調(diào)節(jié)膠原酶和膠原的合成、分泌和沉淀,調(diào)節(jié)膠原降解,使膠原纖維以線性方式排列,增強(qiáng)創(chuàng)面抗張程度,減少疤痕形成,提高愈合質(zhì)量。Receptor-linkedtyrosinekinasessuchastheepidermalgrowthfactorreceptor(EGFR)areactivatedbyextracellularligands.Bindingofepidermalgrowthfactor(EGF)totheEGFRactivatesthetyrosinekinaseactivityofthecytoplasmicdomainofthereceptor.TheEGFRbecomesphosphorylatedontyrosineresidues.DockingproteinssuchasGRB2containsanSH2domainthatbindstothephosphotyrosineresiduesoftheactivatedreceptor.GRB2bindstotheguaninenucleotideexchangefactorSOSbywayofthetwoSH3domainsofGRB2.WhentheGRB2-SOScomplexdockstophosphorylatedEGFR,SOSbecomesactivated.ActivatedSOSthenpromotestheremovalofGDPfromamemberoftheRassubfamily(mostnotablyH-RasorK-Ras).RascanthenbindGTPandbecomeactive.ApartfromEGFR,othercellsurfacereceptorsthatcanactivatethispathwayviaGRB2includeTrkA/B,Fibroblastgrowthfactorreceptor(FGFR)andPDGFR.MAPK/ERKpathwayKinasecascadeActivatedRasactivatestheproteinkinaseactivityofRAFkinase.[4]RAFkinasephosphorylatesandactivatesMEK(MEK1andMEK2).MEKphosphorylatesandactivatesamitogen-activatedproteinkinase(MAPK).RAF,andMAPKarebothserine/threonine-selectiveproteinkinases.MEK(alsoknownasMAPKK)isatyrosine/threoninekinase.Inthetechnicalsense,RAF,MEK,andMAPKareallmitogen-activatedkinases,asisMNK(seebelow).MAPKwasoriginallycalled"extracellularsignal-regulatedkinases"(ERKs)and"microtubule-associatedproteinkinase"(MAPK).OneofthefirstproteinsknowntobephosphorylatedbyERKwasamicrotubule-associatedprotein(MAP).Asdiscussedbelow,manyadditionaltargetsforphosphorylationbyMAPKwerelaterfound,andtheproteinwasrenamed"mitogen-activatedproteinkinase"(MAPK).TheseriesofkinasesfromRAFtoMEKtoMAPKisanexampleofaproteinkinasecascade.Suchseriesofkinasesprovideopportunitiesforfeedbackregulationandsignalamplification.EGFRdimerizationstimulatesitsintrinsicintracellularprotein-tyrosinekinaseactivity.Asaresult,autophosphorylationofseveraltyrosine(Y)residuesintheC-terminaldomainofEGFRoccurs.Thisautophosphorylationelicitsdownstreamactivationandsignalingbyseveralotherproteinsthatassociatewiththephosphorylatedtyrosinesthroughtheirownphosphotyrosine-bindingSH2domains.Thesedownstreamsignalingproteinsinitiateseveralsignaltransductioncascades,principallytheMAPK,AktandJNKpathways,leadingtoDNAsynthesisandcellproliferation.柱狀上皮細(xì)胞:主要分布于鼻腔、鼻咽、器官、肺、胃、腸、子宮頸、子宮內(nèi)膜及輸卵管等部位。鱗狀上皮細(xì)胞:被覆于全身皮膚、口腔、喉部、鼻咽的一部分、食道、陰道的全部以及子宮頸。鱗狀上皮細(xì)胞分為基底層細(xì)胞、中層細(xì)胞和表層細(xì)胞。黏膜是指口腔、鼻腔、腸管、陰道等與外界相通體腔的濕潤(rùn)上皮細(xì)胞。AKTpathwayAktisinvolvedinthePI3K/AKT/mTORpathwayandothersignalingpathways.Bindingphospholipids:AktpossessesaproteindomainknownasaPHdomain,orPleckstrinHomologydomain,namedafterPleckstrin,theproteininwhichitwasfirstdiscovered.Thisdomainbindstophosphoinositideswithhighaffinity.InthecaseofthePHdomainofAkt,itbindseitherPIP3orPIP2Thisisusefulforcontrolofcellularsignalingbecausethedi-phosphorylatedphosphoinositidePIP2isonlyphosphorylatedbythefamilyofenzymes,PI3-kinases(phosphoinositide3-kinaseorPI3-K),andonlyuponreceiptofchemicalmessengerswhichtellthecelltobeginthegrowthprocess.Forexample,PI3-kinasesmaybeactivatedbyaGproteincoupledreceptororreceptortyrosinekinasesuchastheinsulinreceptor.Onceactivated,PI3-kinasephosphorylatesPIP2toformPIP3.Phosphorylation:OncecorrectlypositionedatthemembraneviabindingofPIP3,Aktcanthenbephosphorylatedbyitsactivatingkinases,phosphoinositidedependentkinase1(PDPK1atthreonine308)andthemammaliantargetofrapamycincomplex2(mTORC2atserine473),firstbymTORC2.mTORC2thereforefunctionallyactsasthelong-soughtPDK2molecule,althoughothermolecules,includingintegrin-linkedkinase(ILK)andmitogen-activatedproteinkinase-activatedproteinkinase-2(MAPKAPK2)canalsoserveasPDK2.PhosphorylationbymTORC2stimulatesthesubsequentphosphorylationofAktbyPDPK1.ActivatedAktcanthengoontoactivateordeactivateitsmyriadsubstrates(e.g.mTOR)viaitskinaseactivity.BesidesbeingadownstreameffectorofPI3-kinases,AktcanalsobeactivatedinaPI3-kinase-independentmanner.ACK1orTNK2,anon-receptortyrosinekinase,phosphorylatesAktatitstyrosine176residue,leadingtoitsactivationinPI3-kinase-independentmanner.StudieshavesuggestedthatcAMP-elevatingagentscouldalsoactivateAktthroughproteinkinaseA(PKA)inthepresenceofinsulin.c-JunN-terminalkinases(JNKs)Thec-JunN-terminalkinasesconsistoftenisoformsderivedfromthreegenes:JNK1(fourisoforms),JNK2(fourisoforms)andJNK3(twoisoforms)JNK,byphosphorylation,modifiestheactivityofnumerousproteinsthatresideatthemitochondriaoractinthenucleus.DownstreammoleculesthatareactivatedbyJNKincludec-Jun,ATF2,ELK1,SMAD4,p53andHSF1.ThedownstreammoleculesthatareinhibitedbyJNKactivationincludeNFAT4,NFATC1andSTAT3.Byactivatingandinhibitingothersmallmoleculesinthisway,JNKactivityregulatesseveralimportantcellularfunctionsincludingcellgrowth,differentiation,survivalandapoptosis.血小板衍生生長(zhǎng)因子Plateletd-erivedgrowthfactor,PDGF從血小板中發(fā)現(xiàn),在損傷早期從血小板α顆粒釋放出來(lái),啟動(dòng)并加速組織創(chuàng)傷修復(fù),
主要由血小板合成,在組織受到損傷時(shí)巨噬細(xì)胞、血管平滑肌細(xì)胞、成纖維細(xì)胞、內(nèi)皮細(xì)胞、胚胎干細(xì)胞等也可以合成并釋放PDGF。結(jié)構(gòu):是靠二硫鍵相連的A、B兩條多肽鏈組合成的二聚體。A鏈125/110個(gè)氨基酸,3個(gè)二硫鍵;B鏈109個(gè)氨基酸,3個(gè)二硫鍵生物學(xué)特性:刺激血管平滑肌細(xì)胞、成纖維細(xì)胞、膠質(zhì)細(xì)胞的分裂增生;誘導(dǎo)巨噬細(xì)胞與成纖維細(xì)胞的游走,對(duì)中性粒細(xì)胞、平滑肌細(xì)胞、成纖維細(xì)胞有趨化性;具有縮血管活性;誘導(dǎo)基因表達(dá)。臨床:傷口愈合MAPKpathwayTheadaptorproteinGrb2formsacomplexwithSosbytheGrb2SH3domain.Grb2(or)theGrb2/SoscomplexisrecruitedtothemembranebytheGrb2SH2domainbindingtoactivatedPDGFR-boundSHP2(AlsoknownasPTPN11,acytosolicPTP),therebyallowinginteractionwithRasandtheexchangeofGDPforGTPonRas.WhereastheinteractionbetweenGrb2andPDGFRoccursthroughinteractionwiththeSHP2protein,Grb2bindstoactivatedEGFRthroughShc,anotheradaptorproteinthatformsacomplexwithmanyreceptorsviaitsPTBdomain.Onceactivated,Rasinteractswithseveralproteins,namelyRaf.ActivatedRafstimulatesMAPK-kinase(MAPKKorMEK)byphosphorylatingaSerresidueinitsactivationloop.MAPKKthenphosphorylatesMAPK(ERK1/2)onTandYresiduesattheactivation-loopleadingtoitsactivation.ActivatedMAPKphosphorylatesavarietyofcytoplasmicsubstrates,aswellastranscriptionfactors,whentranslocatedintothenucleus.MAPKfamilymembershavebeenfoundtoregulatevariousbiologicalfunctionsbyphosphorylationofparticulartargetmolecules(suchastranscriptionfactors,otherkinasesetc.)locatedincellmembrane,cytoplasmandnucleus,andthuscontributetotheregulationofdifferentcellularprocessessuchascellproliferation,differentiation,apoptosisandimmunoresponses.PI3Kpathway
TheclassIAphospholipidkinase,PI-3kinase,isactivatedbythemajorityofRTKs.SimilarlytootherSH2domain-containingproteins,PI-3kinaseformsacomplexwithPYsitesonactivatedreceptors.ThemainfunctionofPI3KactivationisthegenerationofPIP3,whichfunctionsasasecondmessengertoactivatedownstreamtyrosinekinasesBtkandItk,theSer/ThrkinasesPDK1andAkt(PKB).ThemajorbiologicalfunctionsofAktactivationcanbeclassifiedintothreecategories–survival,proliferationandcellgrowth.Aktisalsoknowntobeimplicatedinseveralcancers,particularlybreast.PLCγisimmediatelyrecruitedbyanactivatedRTKthroughthebindingofitsSH2domainstophosphotyrosinesitesofthereceptor.Afteractivation,PLCγhydrolysesitssubstratePtdIns(4,5)P2andformstwosecondmessengers,diacylglycerolandIns(1,4,5)P3.Ins(1,4,5)P3stimulatesthereleaseofCa2+fromintracellularsupplies.Ca2+thenbindstocalmodulin,whichsubsequentlyactivatesafamilyofcalmodulindependentproteinkinases(CamKs).Inaddition,bothdiacylglycerolandCa2+activatemembersofthePKCfamily.ThesecondmessengersgeneratedbyPtdIns(4,5)P2hydrolysisstimulateavarietyofintracellularprocessessuchasproliferation,angiogenesis,cellmotility.轉(zhuǎn)化生長(zhǎng)因子Transforminggrowthfactor,TGF兩類多肽類生長(zhǎng)因子,轉(zhuǎn)化生長(zhǎng)因子-α和轉(zhuǎn)化生長(zhǎng)因子-β。TGFαisupregulatedinsomehumancancers.Itisproducedinmacrophages,braincells,andkeratinocytes,andinducesepithelialdevelopment.TGFβexistsinthreeknownsubtypesinhumans,TGFβ1,TGFβ2,andTGFβ3.TheseareupregulatedinMarfan'ssyndromeandsomehumancancers,andplaycrucialrolesintissueregeneration,celldifferentiation,embryonicdevelopment,andregulationoftheimmunesystem.轉(zhuǎn)化生長(zhǎng)因子-αItisproducedinmacrophages,braincells,andkeratinocyt
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 二零二五年度高性能地板磚研發(fā)、生產(chǎn)與銷售合作協(xié)議3篇
- 2025年水電站經(jīng)營(yíng)權(quán)整體轉(zhuǎn)讓協(xié)議3篇
- 二零二五版智能辦公空間裝修與系統(tǒng)集成服務(wù)合同2篇
- 二零二五版公共場(chǎng)合甲醛濃度檢測(cè)與治理合同范本2篇
- 個(gè)體經(jīng)營(yíng)者與員工勞動(dòng)合同(2024年適用)3篇
- 二零二五年度工業(yè)廠區(qū)園區(qū)內(nèi)教育培訓(xùn)機(jī)構(gòu)合作合同3篇
- 2025年度建筑工程漏水鑒定與免責(zé)賠償協(xié)議4篇
- 二零二五年度特許經(jīng)營(yíng)合同糾紛原告代理詞4篇
- 2025年度綠化苗木種植與養(yǎng)護(hù)一體化服務(wù)合同4篇
- 2025版路面硬化工程與排水系統(tǒng)建設(shè)合同規(guī)范4篇
- 2024年四川省德陽(yáng)市中考道德與法治試卷(含答案逐題解析)
- 施工現(xiàn)場(chǎng)水電費(fèi)協(xié)議
- SH/T 3046-2024 石油化工立式圓筒形鋼制焊接儲(chǔ)罐設(shè)計(jì)規(guī)范(正式版)
- 六年級(jí)數(shù)學(xué)質(zhì)量分析及改進(jìn)措施
- 一年級(jí)下冊(cè)數(shù)學(xué)口算題卡打印
- 真人cs基于信號(hào)發(fā)射的激光武器設(shè)計(jì)
- 【閱讀提升】部編版語(yǔ)文五年級(jí)下冊(cè)第三單元閱讀要素解析 類文閱讀課外閱讀過(guò)關(guān)(含答案)
- 四年級(jí)上冊(cè)遞等式計(jì)算練習(xí)200題及答案
- 法院后勤部門(mén)述職報(bào)告
- 2024年國(guó)信證券招聘筆試參考題庫(kù)附帶答案詳解
- 道醫(yī)館可行性報(bào)告
評(píng)論
0/150
提交評(píng)論